Gilead Sciences | Capitale Sociale E Riserve

Prezzo Delle Azioni
152.50
Cambio Giornaliero
3.13 2.10%
Mensile
22.64%
Annuale
58.79%
Q1 Previsione
147.82




Capitale Sociale E Riserve Cambiamento Data
AbbVie USD -2.64B 2.46B 2025-09
Agios Pharmaceuticals USD 1.28B 85.22M 2025-09
ALKERMES USD 1.73B 108.85M 2025-09
Alnylam Pharmaceuticals USD 233.89M 16.7M 2025-09
Amgen USD 9.62B 2.19B 2025-09
Biogen USD 18.21B 573.5M 2025-09
BioMarin Pharmaceutical USD 6.06B 29.6M 2025-09
Bristol-Myers Squibb USD 18.55B 1.06B 2025-09
Eli Lilly USD 23.79B 5.52B 2025-09
Gilead Sciences USD 21.46B 1.78B 2025-09
GlaxoSmithKline GBP 16.38B 229M 2025-12
Glaxosmithkline GBP 21.7B 7.35B 2025-09
Incyte USD 4.65B 480.29M 2025-09
J&J USD 78.47B 0 2025-09
Merck USD 51.85B 2.79B 2025-09
Moderna USD 9.33B 69M 2025-09
Neurocrine Biosciences USD 3B 309.3M 2025-09
Novartis USD 44.75B 2.7B 2025-09
Pfizer USD 92.8B 4.11B 2025-09
PTC Therapeutics USD -155.76M 50.79M 2025-09
Regeneron Pharmaceuticals USD 31.26B 299.1M 2025-12
Sanofi EUR 71.71B 1.55B 2025-12
Sarepta Therapeutics USD 1.32B 37.26M 2025-09
United Therapeutics USD 6.59B 583.4M 2025-09
Vertex Pharmaceuticals USD 17.32B 143.4M 2025-09


Gilead Sciences Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.